Cita APA

Mestre, L., Redondo, M., Carrillo-Salinas, F. J., Morales-García, J. A., Alonso-Gil, S., Pérez Castillo, A., . . . Guaza, C. (2015). PDE7 inhibitor TC3.6 ameliorates symptomatology in a model of primary progressive multiple sclerosis.

Citación estilo Chicago

Mestre, Leyre, Miriam Redondo, F. J. Carrillo-Salinas, José A. Morales-García, Sandra Alonso-Gil, Ana Pérez Castillo, Carmen Gil, Ana Martínez Gil, y Carmen Guaza. PDE7 Inhibitor TC3.6 Ameliorates Symptomatology in a Model of Primary Progressive Multiple Sclerosis. 2015.

Cita MLA

Mestre, Leyre, et al. PDE7 Inhibitor TC3.6 Ameliorates Symptomatology in a Model of Primary Progressive Multiple Sclerosis. 2015.